# Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1

> **NCT01661621** · PHASE4 · COMPLETED · sponsor: **Buddhist Tzu Chi General Hospital** · enrollment: 395 (actual)

## Conditions studied

- Bladder Outlet Obstruction

## Interventions

- **DRUG:** Detrusitol 4 mg QD
- **DRUG:** Doxazosin 4 mg QD

## Key facts

- **NCT ID:** NCT01661621
- **Lead sponsor:** Buddhist Tzu Chi General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 395 (ACTUAL)
- **Last updated:** 2014-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01661621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01661621, "Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01661621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*